Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1 þ /À murine fibroblast cells (MEF) were defective in undergoing G 2 /M arrest. Thus, whereas in the presence of DNA damage BubR1
MEF cells remained arrested in mitosis, BubR1
þ /À MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1 þ /À MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADPribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1 þ /À MEFs upon treatment
Introduction
The spindle checkpoint functions to prevent premature anaphase entry until each of every condensed chromosome successfully attaches to bipolar spindle microtubules. BubR1 is a key molecule mediating spindlecheckpoint activation, during which it is extensively phosphorylated (Li et al., 1999) . A loss of spindlecheckpoint function inevitably results in chromosomal instability and aneuploidy (Lengauer, 2003; Bharadwaj and Yu, 2004) . Given that aneuploidy is prevalent in many types of cancers it is believed that spindlecheckpoint failure may be at least partly responsible for the development of cancer . Mutations in BubR1 have been detected in colonic cancer (Cahill et al., 1998) . Our mouse genetic study shows that haplo-insufficiency of BubR1 results in enhanced genomic instability and development of cancer in lung and colon (Dai et al., 2004; Rao et al., 2005) .
Consistently, a recent study shows that a compromised BubR1 activity due to specific germline mutations causes aneuploidy, infertility and/or early onset of malignancies (Hanks et al., 2004) , strongly suggesting that spindle checkpoint failure is an underlying cause for the development of certain diseases. The signaling pathways that underlie the cellular response to DNA damage (genotoxic stress) consist of sensors, signal transducers, and effectors (Zhou and Elledge, 2000; Sancar et al., 2004) . Although the identities of the damage sensors remain unknown, the molecular entities responsible for transducing the damage signals to specific effectors are relatively well characterized. ATM (mutated in ataxia telangiectasia) and its homologue ATR (ATM-related) function early in the signaling pathways and are central to the DNA damage response. Downstream targets (substrates) of ATM and ATR include the protein kinases Chk1, Chk2, and Plks (Smits et al., 2000; Sancar et al., 2004; Xie et al., 2005) . Effector molecules that execute the DNA damage response include p53. ATM and ATR, together with Chk1, Chk2, and Plk3, are thought to mediate the specific cellular responses to different types of DNA damage in mammalian cells.
Securin is a major molecular target of anaphasepromoting complex/cyclosome (APC/C) (Lew and Burke, 2003; Bharadwaj and Yu, 2004) and it also interacts with p53 (Bernal et al., 2002; Hamid and Kakar, 2003) . It has been proposed that the oncogenic effect of increased expression of securin may result from modulation of p53 functions (Bernal et al., 2002) . On the other hand, securin is, in turn, a transcriptional target of p53 (Zhou et al., 2003) . Given the observed transforming ability of securin (Hamid and Kakar, 2003) , it is speculated that securin may negatively regulate p53 in a manner similar to that of MDM2. In this study, we show that BubR1 þ /À murine fibroblasts (MEFs) exhibited a compromised mitotic arrest after DNA damage, which was accompanied by significantly reduced levels of phospho-H2AX, p53 and p21. In addition, we demonstrate that Poly(ADP-ribose) polymerase 1 (PARP-1) interacted and colocalized with BubR1 and that PARP-1 degradation was enhanced when cellular BubR1 levels were reduced.
Results
DNA damage frequently induces G 2 /M arrest (Sancar et al., 2004) . Existing evidence indicates that certain DNA damage results in defective interaction between chromosomes and kinetochores that in turn activates the spindle checkpoint (Mikhailov et al., 2002; Nitta et al., 2004) . It has been shown that suppression of spindlecheckpoint function by downregulation of BubR1 and Mad2 via RNA interference causes abnormal mitosis, even in the presence of DNA damage (Nitta et al., 2004) . To study whether spindle-checkpoint defects would compromise DNA damage responses, we examined BubR1-deficient (BubR1 þ /À ) cells for their cell-cycle status after DNA damage. Paired BubR1 þ /À and wildtype (BubR1 þ / þ ) MEF cells, as well as HeLa cells, were treated with doxorubicin, a DNA topoisomerase 2 inhibitor causing DNA double-strand breaks, for various time intervals, and cells were then fixed and stained with DAPI for analysis by flow cytometry. As expected, an increasing proportion of HeLa cells were arrested at G 2 /M stages of the cell cycle after exposure to doxorubicin (Figure 1a ). Similar to HeLa cells, a significant fraction of wild-type MEFs were also rapidly arrested in G 2 /M after DNA damage; on the other hand, G 2 /M arrest was not apparent with BubR1
MEFs even 9 h after exposure to the drug (Figure 1a ), suggesting that a defective spindle checkpoint weakens cell's ability to undergo G 2 /M arrest after DNA damage. To further determine whether cells with DNA damage were incapable of undergoing mitotic arrest in BubR1 þ /À MEFs, we treated BubR1 þ /À and wild-type MEFs for 16 h with nocodazole that induces mitotic arrest. The mitotically arrested cells were then cultured in fresh medium free of nocodazole but supplemented with doxorubicin. We observed that mitotic BubR1 þ /À MEFs gradually exited from mitosis and only a minor fraction of cells remained in G 2 /M 9 h after release. In fact, the presence of a distinct cohort of BubR1 þ /À cells synchronized in early S-phase indicates that the cells have divided and then exited G 1 phase of the cycle. In contrast, a majority of BubR1 þ / þ MEFs remained in G 2 /M 9 h post release ( Figure 1b) . We then quantified the G 2 /M fraction of paired MEFs at various time intervals post nocodazole release in the presence of doxorubicin. After DNA damage, a large fraction of BubR1 þ / þ MEFs remained at G 2 /M stages; in the absence of doxorubicin, the G 2 /M population signifi- þ / þ and BubR1 þ /À MEFs of the third passage were treated with nocodazole for 16 h. The cells were then released from nocodazole block and cultured in the presence or absence of doxorubicin for various times. The percent of G 2 /M cells were calculated. These experiments were repeated for at least two times with independent lines of primary MEFs and representative data were presented.
BubR1 deficiency and DNA damage checkpoint Y Fang et al cantly decreased 6 h after nocodazole release ( Figure 1c ). On the other hand, BubR1 þ /À MEFs exited from G 2 /M phases in a similar kinetics regardless of the DNA damage status (Figure 1c ), thus consistent with the notion that BubR1 deficiency compromised G 2 /M arrest induced by DNA damage.
To examine whether the defective cell-cycle arrest in BubR1 þ /À cells was accompanied by a weakened DNA damage response, we analysed the level of phosphohistone 2AX (p-H2AX), a marker tightly associated with the extent of DNA damage (Redon et al., 2002) , in paired MEFs treated with doxorubicin for various intervals. Whereas little p-H2AX was detectable in untreated wild-type or BubR1 þ /À MEFs, much stronger H2AX phosphorylation was induced by doxorubicin treatment (Figure 2a ). The magnitude of increase in p-H2AX signals was more pronounced in wild-type MEFs than that of BubR1 þ /À MEFs. In fact, p-H2AX was barely inducible in BubR1 þ /À cells by doxorubicin ( Figure 2a ). Similar results were also obtained with paired MEFs exposed to UV irradiation. In wild-type MEFs, phospho-H2AX was detectable 12 h after UV exposure and increased significantly by 24 h; however, little phospho-H2AX was detected in BubR1 þ /À MEFs even 24 h after UV irradiation ( Figure 2b ).
The tumor suppressor protein p53 plays an important role in DNA damage responses (Zhou and Elledge, 2000) and it also interacts with securin (Hamid and Kakar, 2003) . Securin is a ubiquitylation target of APC/ C whose E3 ligase activity is, in turn, regulated by the spindle checkpoint (Lengauer, 2003; Bharadwaj and Yu, 2004 ). We then examined the level of p53 in paired MEFs. The basal level of p53 was significantly lower in BubR1 þ /À MEFs than that in wild type; consistently, the basal level of p21 was also lower in untreated BubR1 þ /À MEFs ( Figure 2c ). Upon exposure to doxorubicin, expression of both p53 and p21 in wild type, but not in BubR1 þ /À MEFs, was significantly induced (Figure 2c ). Interestingly, expression of p21, but not p53, was drastically reduced 12 h after doxorubicin treatment in BubR1 þ /À cells ( Figure 2c ). To further confirm the observation that BubR1 deficiency compromises p53 activation after DNA damage, we exposed paired MEFs to UV and then analysed p53 and p21 expression at various time intervals post UV exposure. Consistently, UV treatment caused a significant accumulation of both p53 and p21 in wild-type MEFs; on the other hand, no significant induction of p53 and p21 was detected in BubR1
MEFs until 24 h after UV exposure (Figure 2d) .
We next examined expression of p21, as well as securin and cyclin B1, in HeLa cells (which express no detectable levels of p53) depleted of BubR1 via RNAi. We demonstrated that p21 expression was also greatly reduced after knockdown of BubR1; as expected, securin and cyclin B1 levels were significantly decreased (Figure 3a) . To further confirm the correlation of BubR1 knockdown with impaired p53 function in human cells, we transfected 293 cells (which express both p53 and p21) with BubR1 siRNA as well as control siRNA. Consistently, BubR1 knockdown significantly reduced p53 and p21 levels in 293 cells (Figure 3b ). We also noticed that doxorubicin treatment significantly reduced viability of both wild-type and BubR1 þ /À MEF and the cell viability was inversely correlated with the concentrations of the DNA damage drug used in the assays; however, BubR1 þ /À MEFs survived significantly better than the wild-type MEFs when they were exposed to the same concentrations of doxorubicin (Figure 3c ), strongly suggesting the involvement of BubR1 in modulation of cellular responses to DNA damage.
We next asked whether DNA damage would affect BubR1 levels because it has been shown that an intact spindle-checkpoint function is required for mitotic þ / þ and BubR1 þ /À MEFs were treated with doxorubicin (0.5 mM) for various time intervals. Equal amounts of cell lysates were blotted for p53, p21, and b-actin.
and BubR1 þ /À MEFs exposed to UV irradiation for various times were lysed and equal amounts of cell lysates were blotted for p53, p21 and b-actin. The MEFs used in this series of experiments were in their fourth passage. Each experiment was repeated for at least three times. Representative results were shown.
BubR1 deficiency and DNA damage checkpoint Y Fang et al catastrophe induced as a result of DNA damage (Nitta et al., 2004) . Doxorubicin treatment for 18 h or longer significantly decreased BubR1 levels in both wild-type and BubR1 þ /À MEFs (Figure 4a ). The same decrease in BubR1 levels was also observed when BubR1 þ /À MEFs were exposed to UV (data not shown). In addition, when HeLa cells were treated with doxorubicin, BubR1 levels were also decreased; the DNA damage-induced downregulation of BubR1 appeared to be specific because MAD2 levels were not affected by doxorubicin treatment of HeLa cells (Figure 4b ). To examine whether DNA damage-induced downregulation of BubR1 was proteasome-dependent, we treated HeLa cells with MG132 with doxorubicin in the presence or absence of the proteasome inhibitor MG132. We observed that neither MG132 alone nor in combination with doxorubicin further induced BubR1 (Figure 4c) . Interestingly, MG132 preferentially stabilized the activated, phosphorylated form of BubR1 (p-BubR1 in Figure 4c ).
To understand the molecular basis by which BubR1 modulates the DNA damage response, experiments were designed to screen and identify proteins that were not only involved in DNA damage responses but also interacted with BubR1. To this end, BubR1 antibody, as well as the control antibody, was immobilized to protein A/G resin, which was subsequently used to enrich proteins from HeLa cell lysates. After thorough washings, proteins bound to BubR1 antibody resin, as well as to the control antibody resin, were eluted and analysed by SDS-PAGE followed by silver staining. We observed that BubR1 antibody, but not the control antibody, was capable of pulling down distinct proteins from both interphase and mitotic lysates (Figure 5a ). The identity of BubR1 bands (both phosphorylated and non-phosphorylated) in eluents was confirmed by immunoblotting. More than a dozen of the visible bands were excised from the gel and subjected to protein identification by mass spectrometric analysis. Among two dozen of the proteins identified, we noticed several hits of PARP-1, which is a protein known to interact We then confirmed the physical interaction between PARP-1 and BubR1 via reciprocal co-immunoprecipitation. PARP-1 antibody, but not the control antibody, was capable of pulling down BubR1 from both interphase and mitotic cell lysates (Figure 5b ). Likewise, BubR1 antibody was able to precipitate p89 fragment of PARP-1 (Figure 5c ). A recent study has shown that Poly(ADP-ribose) (PAR) is an essential component of the mitotic spindle that is involved in bipolar spindle assembly and function (Chang et al., 2004) . Given the observation that PARP-1 interacts with kinetochore components such as CENP-A, CENP-B, and Bub3 (Saxena et al., 2002) , we asked whether PARP-1 shares the same subcellular localization as BubR1 during early mitosis when BubR1 is activated. Indirect immunofluorescent microscopy revealed that PARP-1 colocalized with BubR1 at kinetochores during prophase (Figure 6a ), suggesting a potentially functional interaction between these two proteins.
As it has also been shown that PARP-1 interacts with p53 and positively regulates p53 activity (Wieler et al., 2003) , we then examined the level of PARP-1 and its degradation product p89 in BubR1 þ /À MEFs before and after doxorubicin treatment. There was a low basal level of PARP-1 in BubR1 þ /À MEFs before initiation of doxorubicin treatment. DNA damage induced by doxorubicin resulted in accumulation of p89 in both wild-type and BubR1 þ /À MEFs, which was correlated with the concomitant decrease in PARP-1 levels; however, the accumulation of p89 in BubR1 þ /À cells was significantly attenuated compared with that of wildtype MEFs (Figure 6b ), indicating that haplo-insufficiency of BubR1 enhances degradation of PARP-1. Moreover, when paired MEFs were exposed to UV for 24 h, the levels of both PARP-1 and p89 in BubR1 
þ /À MEFs of the fourth passage were exposed to UV irradiation. At 24 h post UV exposure, cells were collected and lysed. Equal amounts of control and treated cell lysates were blotted for PARP-1, p89, and b-actin. These experiments were repeated with three independent lines of primary MEFs (in the third or fourth passage) and similar results were obtained. (d) HeLa cells were transfected with BubR1 or luciferease (Luc) siRNA for 2 days after which cells were lysed and equal amounts of cell lysates in duplicates were blotted for BubR1, PARP-1, and b-actin.
BubR1 deficiency and DNA damage checkpoint Y Fang et al
MEFs were also significantly decreased compared with that of wild-type cells (Figure 6c ). The enhanced degradation of PARP-1 owing to BubR1 deficiency was also demonstrated in HeLa cells. After BubR1 knockdown via RNAi, the basal level of PARP-1 was significantly reduced as compared with that of untransfected cells or the cells transfected with luciferase siRNA (Figure 6d ).
Discussion
In this report, we demonstrate that an impaired spindle checkpoint owing to BubR1 deficiency also compromises the cell's ability to respond to DNA damage induced by both UV and the double-strand break mimetic drug doxorubicin. Specifically, BubR1
þ /À cells failed to undergo significant mitotic arrest in the presence of DNA damage. These cells also had a reduced ability to accumulate phosphorylated H2AX, a marker strongly associated with DNA repair and apoptosis. Expression of both p53 and p21 was significantly compromised in BubR1-deficient cells before and after DNA damage. Moreover, BubR1 deficiency facilitated degradation of PARP-1, especially after DNA damage. BubR1 colocalized with PARP-1 in the cell and physically interacted with this protein. Given that both p53 and PARP-1 are important components in DNA damage checkpoint activation (Huber et al., 2004) , our studies strongly suggest that spindle-checkpoint impairment owing to BubR1 deficiency weakens cell's ability to cope with genotoxic stresses.
It is known that p53 levels are kept low in the cells through ubiquitylation and proteasomal degradation (Yang et al., 2004) . Upon various stresses, p53 is stabilized and activated through diverse pathways that include inhibition of ubiquitylation. As defects in p53 are present in more than half of all human tumors, it would be logical to ask whether spindle-checkpoint defects would affect the level of p53. Our studies show that compared with wild-type MEFs, p53 was greatly reduced in BubR1 þ /À MEFs before and after DNA damage; the decreased level of p53 was correlated with reduced expression of p21 (Figure 2c  and d) . It has been shown that p53 is physically associated with securin (Hamid and Kakar, 2003) , whose degradation is enhanced owing to an elevated activity of APC/C Cdc20 . Although it remains unclear at present whether APC/C Cdc20 direclty poly-ubiquitylates p53, it is reasonable to speculate that accelerated degradation of securin by the proteasomal pathway in BubR1 þ /À MEFs may facilitate degradation of those proteins associated with it.
Expression of p53 is induced in wild-type MEFs, which was accompanied by enhanced p21 expression (Figure 2c) , consistent with the fact that p21 is a transcriptional target of p53. On the other hand, p21 expression in BubR1 þ /À MEFs appears to be less coordinated with p53 expression. For example, after treatment with doxorubicin for more than 6 h, BubR1 þ /À MEFs contained little, if any, p21 although a significant amount of p53 was detected in these cells (Figure 2c ). In addition, BubR1 knockdown via RNAi caused a drastic reduction of p21 in HeLa cells that do not have detectable levels of p53 before or after DNA damage (data not shown). As p21 is also degraded by the proteasome-mediated pathway (Bloom et al., 2003) , it is interesting to know whether elevated APC/C Cdc20 activity would modulate its poly-ubiquitylation in BubR1-deficient cells. A recent study shows that APC/C Cdh1 participates in the regulation of SCF(Skp2-Cks1) activity, which in turn is responsible for the degradation of p21 and p27 (Bashir et al., 2004) . As Skp2 is a target of APC/C Cdh1 , it would be interesting to test whether there is a cross-talk between APC/C Cdc20 and SCF. The APC/C Cdc20 activity is directly affected by an impaired spindle checkpoint owing to BubR1 deficiency. Thus, it is natural to observe that securin levels are decreased in BubR1 þ /À cells ( Figure 3a ). Here we show that p53 and PARP-1 protein levels are also decreased in BubR1-deficient cells. Given that both p53 and PARP-1 play important role in DNA repair and that BubR1 þ /À mice are prone to the development of cancers it is tempting to propose that haplo-insufficiency of BubR1 can cause genetic instabilities at levels of both DNA repair and chromosomal segregation, deregulation of which will inevitably result in malignant transformation.
We have shown that both BubR1 and PARP-1 were degraded after DNA damage (Figures 4 and 6) . Although PARP-1 cleavage is mediated by caspase 3 (Affar et al., 2001) , the molecular entity responsible for degradation of BubR1 after genotoxic stresses remains unknown. As inhibition of proteasome by MG132 can partially block the degradation of BubR1, especially the phosphorylated form ( Figure 5 ), we speculate that the proteasomal pathway is involved in regulating the stability of BubR1 after DNA damage. It is interesting to note that MAD2 is not degraded after DNA damage although it functions in the same way in inhibition of APC/C activity as BubR1 (Bharadwaj and Yu, 2004) , suggesting that not all spindle checkpoint components are regulated by the same molecular pathway.
A recent study shows that PAR is enriched at the mitotic spindle and essential for spindle function (Chang et al., 2004) . Polymerization of PAR on target proteins is catalyzed by PARPs (Chang et al., 2004) . Early studies have shown that PARP-1 and PARP-2 localize to centrosomes and interact with kinetochore proteins such as CENP-A, CENP-B, and Bub3 (Saxena et al., 2002) . In addition, cellular PAR concentrations are greatly elevated in mitosis owing to an increased PARP activity (Pirrotta, 2004) . All of these studies suggest the importance of PAR and PARP enzymes during mitotic progression. Our observations that BubR1 interacts with PARP-1 and that it colocalizes with PARP-1 during prophase also strongly support the notion that PARPs may play a critical role in regulating chromosomal segregation as well as DNA damage responses.
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Materials and methods

MEF cells Primary BubR1
þ /À and wild-type MEF cells were derived from embryonic day 14.5 (E14.5) embryos produced from BubR1 þ /À intercrosses. MEF cells were cultured under 5% CO 2 in Dulbecco minimum essential medium (DMEM) supplemented with 0.1 mM b-mercaptoethanol, 15% fetal bovine serum (FBS), and antibiotics (100 mg/ml penicillin and 50 mg/ml streptomycin sulfate). MEFs of the third to fifth passages were used for experiments. HeLa and 293 cells were cultured in DMEM supplemented with various components as above.
Indirect immunofluorescence microscopy and flow cytometry Immunoflouresence microscopy was essentially as described (Wang et al., 2002) . Briefly, cells were fixed in paraformaldehyde and then treated with 0.1% Triton X-100. After washing three times with phosphate-buffered saline (PBS), the cells were blocked in 2.0% bovine serum albumin (BSA) for 15 min on ice and incubated with antibodies to BubR1 or PARP-1 (Cell Signaling) for 1 h. After additional washing with PBS, the cells were incubated with appropriate secondary antibodies conjugated with Rhodamine-Red-X or fluorescein (Jackson Immuno-Research) at 41C for 1 h in the dark. Cells were then briefly (5 min) stained with 4 0 ,6-diamidino-2-phenylindole (DAPI, Fluka). Fluorescence microscopy was performed on a Nikon microscope and images were captured using a digital camera (Optronics) using Optronics MagFire, Image-Pro Plus softwares. For flow cytometric analysis, primary MEFs were fixed in suspension in 70% ethanol, then stained with 1 mg/ml of DAPI dissolved in PBS, and intensity of their blue fluorescence was measured using Elite.ESP flow cytometer/ sorter (Beckman Coulter). The DNA content frequency histograms were deconvoluted with MultiCycle software (Phoenix Flow Systems).
Western blotting
Primary MEFs or HeLa cells were treated with doxorubicin (0.5 mM, unless otherwise specified) or UVC (25 J/m 2 ). MEFs or HeLa cells were lysed in a lysis buffer as described (Ouyang et al., 1997) and an equal amount of cell lysates were subjected to SDS-PAGE followed by immunoblotting analysis with antibodies to BubR1, p53 (Cell Signaling), PARP-1 (Cell Signaling), securin (MBL), cyclin B1 (Cell Signaling), or bactin (Sigma). Specific signals were detected with horseradishperoxidase-conjugated goat-anti-rabbit secondary antibodies (Sigma) and enhanced chemiluminescence reagents (Amersham Pharmacia Biotech).
Cell viability/survival assay Cell viability was assayed by the MTT method. Primary MEFs (2 Â 10 4 cells/well) were seeded on 96-well plate in triplicates. Following a 24-h culture at 371C, the culture medium was aspirated and a fresh medium supplemented with various concentrations of doxorubicin was added to a final volume of 200 ml. After 24 h incubation, 20 ml of MTT (Sigma, 2 mg/ml in PBS) was then added to each well. After the cells were incubated at 371C for 4 h, the medium was removed. MTT formazan precipitates were dissolved in 100 ml DMSO with mechanical shaking for 10 min. The optical density of dissolved samples was measured at 570 nm using a plate reader.
RNA interference Double-stranded RNAs of 21 nucleotides in length were synthesized by Dharmacon Research. The targeting sequence was 5 0 -AAGGGAAGCCGAGCUGUUGAC-3 0 , corresponding to the coding region of 1281-1301 in human BubR1 (accession no., AF068760) relative to the first nucleotide of ATG start codon. The control siRNA targets luciferase mRNA (accession no., X65324) of the firefly (Photinus pyralis) and the targeting sequence was 5 0 -UUCCTACGCTGAGTAC TTCGA-3 0 (GL-3, Dharmacon Research). Double nucleotides (dTdT) were added at the 3 0 -end of each strand. RNA duplexes were transfected into HeLa or 293 cells via the Lipofectamine 2000 approach (Invitrogen). Cells transfected with BubR1 and luciferase siRNAs for 2 days were collected and lysed, and an equal amount of cell lysates were blotted for expression of BubR1, p21, securin, cyclin B1, PARP-1, and b-actin via immunoblotting.
Immunoprecipitation and mass spectrometry HeLa cells were cultured in the presence or absence of nocodazole (0.5 mg/ml) for 16 h. Lysates were prepared from mitotic as well as interphase cells immediately. After preclearing with protein A/G beads (Santa Cruz), protein lysates of interphase and mitotic stages (10 mg each) were incubated with anti-BubR1 antibody (40 mg) overnight at 41C. Protein A/ G beads were then added to the lysates and the incubation continued at room temperature for 1 h. After extensive washing with the lysis buffer, protein A/G beads were suspended in SDS-PAGE sample buffer. BubR1 and BubR1-interacting proteins were analysed on a 6% denaturing polyacrylamide gel, which was subsequently subjected to silver staining using a kit from Bio-Rad. Major bands were excised and subjected to protein identification using a tandem MS/MS mass spectrometer (Proteomics Core facility at Rockefeller University).
